GT Biopharma, Inc. (GTBP)

CIK 109657 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for GT Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Oct 20, 2026EFFECT9999999995-26-003305
Oct 20, 2026424B30001493152-26-047792
Oct 13, 2026DEF 14A0001493152-26-046861
Oct 9, 2026S-10001493152-26-046618
Oct 2, 2026PRE 14A0001493152-26-045611
Sep 29, 2026D0000109657-26-000001
Sep 25, 20268-K0001493152-26-044309
Sep 21, 20268-K0001493152-26-043562
Sep 15, 2026SCHEDULE 13G0001213900-26-100247
Sep 15, 20268-K0001493152-26-042672
Sep 3, 20268-K0001493152-26-041333
Aug 14, 202610-Q0001493152-26-037988
Aug 14, 20268-K0001493152-26-038446
Jul 2, 2026DEF 14A0001493152-26-031922
Jun 18, 2026PRE 14A0001493152-26-029362
Jun 12, 20268-K0001493152-26-028457
May 22, 20268-K0001493152-26-024913
May 15, 202610-Q0001493152-26-023346
May 13, 2026424B30001493152-26-022795
May 13, 2026EFFECT9999999995-26-001620
Apr 30, 2026S-10001493152-26-020697
Apr 7, 20268-K0001493152-26-015413
Mar 6, 202610-Q/A0001493152-26-009126
Mar 6, 202610-Q/A0001493152-26-009127
Mar 2, 20268-K0001493152-26-008442